| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |